• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉畸形:儿童期和青春期的进展风险

Venous malformation: risk of progression during childhood and adolescence.

作者信息

Hassanein Aladdin H, Mulliken John B, Fishman Steven J, Alomari Ahmad I, Zurakowski David, Greene Arin K

机构信息

Department of Plastic and Oral Surgery, Vascular Anomalies Center, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Ann Plast Surg. 2012 Feb;68(2):198-201. doi: 10.1097/SAP.0b013e31821453c8.

DOI:10.1097/SAP.0b013e31821453c8
PMID:21629093
Abstract

Venous malformations (VMs) can cause significant morbidity, particularly because they enlarge over time and become symptomatic. The purpose of this study was to determine the natural progression of VMs to facilitate patient counseling, gain insight into pathophysiology, and guide therapy. Our Vascular Anomalies Center database was reviewed for patients with cutaneous and soft-tissue VMs. Predictive variables were age, gender, location, pregnancy, and size. The outcome variable was natural progression of the malformation defined by expansion of the lesion or the onset/worsening of symptoms. The study included 614 patients. Children had a 26.1% risk of progression prior to adolescence, 74.9% before adulthood, and 93.2% over their lifetime. Progression was more likely in adolescence (60.9%) than in childhood (22.5%); the relative risk was 2.6 (95% confidence interval, 2.1-3.2) (P = 0.0001). Diffuse VMs progressed more often than localized lesions (P = 0.002); extremity and trunk VMs worsened more frequently than head/neck lesions (P = 0.03). VMs have a higher risk of progression in adolescents than in children; pubertal hormones may contribute to expansion. Because of their high rate of progression, early treatment of asymptomatic VMs should be considered.

摘要

静脉畸形(VMs)可导致严重的发病情况,尤其是因为它们会随着时间推移而增大并出现症状。本研究的目的是确定静脉畸形的自然进展情况,以方便对患者进行咨询、深入了解病理生理学并指导治疗。我们对血管畸形中心数据库中患有皮肤和软组织静脉畸形的患者进行了回顾。预测变量包括年龄、性别、位置、妊娠情况和大小。结局变量是由病变扩大或症状出现/加重所定义的畸形自然进展情况。该研究纳入了614例患者。儿童在青春期前进展的风险为26.1%,成年前为74.9%,终生为93.2%。进展在青春期(60.9%)比在儿童期(22.5%)更常见;相对风险为2.6(95%置信区间,2.1 - 3.2)(P = 0.0001)。弥漫性静脉畸形比局限性病变进展更频繁(P = 0.002);四肢和躯干的静脉畸形比头颈部病变恶化更频繁(P = 0.03)。静脉畸形在青少年中的进展风险高于儿童;青春期激素可能促使其扩大。由于其高进展率,应考虑对无症状的静脉畸形进行早期治疗。

相似文献

1
Venous malformation: risk of progression during childhood and adolescence.静脉畸形:儿童期和青春期的进展风险
Ann Plast Surg. 2012 Feb;68(2):198-201. doi: 10.1097/SAP.0b013e31821453c8.
2
Lymphatic malformation: risk of progression during childhood and adolescence.淋巴管畸形:儿童期和青少年期进展风险
J Craniofac Surg. 2012 Jan;23(1):149-52. doi: 10.1097/SCS.0b013e3182413ea8.
3
Early versus later presentations of venous malformations: where and why?静脉畸形的早期与晚期表现:部位及原因何在?
Pediatr Dermatol. 2013 Sep-Oct;30(5):534-40. doi: 10.1111/pde.12162. Epub 2013 May 16.
4
The results of surgical treatment for patients with venous malformations.静脉畸形患者的手术治疗结果。
Ann Vasc Surg. 2012 Jul;26(5):665-73. doi: 10.1016/j.avsg.2011.12.004.
5
Aspirin therapy in venous malformation: a retrospective cohort study of benefits, side effects, and patient experiences.阿司匹林治疗静脉畸形:一项关于益处、副作用及患者体验的回顾性队列研究。
Pediatr Dermatol. 2014 Sep-Oct;31(5):556-60. doi: 10.1111/pde.12373. Epub 2014 Jul 21.
6
Classification of venous malformations in children and implications for sclerotherapy.儿童静脉畸形的分类及其对硬化治疗的意义。
Pediatr Radiol. 2003 Feb;33(2):99-103. doi: 10.1007/s00247-002-0838-9. Epub 2002 Nov 19.
7
Evaluation of pain incidence due to venous malformation based on data from 85 institutions in Japan.基于日本 85 家医疗机构的数据评估静脉畸形所致疼痛的发生率。
J Vasc Surg Venous Lymphat Disord. 2020 Mar;8(2):244-250. doi: 10.1016/j.jvsv.2019.03.008. Epub 2019 Aug 27.
8
MRI phenotypes of localized intravascular coagulopathy in venous malformations.静脉畸形中局限性血管内凝血病的磁共振成像表现型
Pediatr Radiol. 2015 Oct;45(11):1690-5. doi: 10.1007/s00247-015-3389-6. Epub 2015 Jul 5.
9
Craniofacial venous malformations: magnetic resonance imaging features that predict treatment outcome.颅面部静脉畸形:预测治疗效果的磁共振成像特征
J Oral Maxillofac Surg. 2009 Nov;67(11):2388-96. doi: 10.1016/j.joms.2008.08.041.
10
Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients.肢体和躯干静脉畸形患者的凝血障碍:118例病例系列
Arch Dermatol. 2008 Jul;144(7):861-7. doi: 10.1001/archderm.144.7.861.

引用本文的文献

1
Alcohol embolization versus non-invasive treatment for pain relief in peripheral venous malformations: a comparative study.酒精栓塞与非侵入性治疗缓解外周静脉畸形疼痛的比较研究
Cardiovasc Diagn Ther. 2025 Jun 30;15(3):598-609. doi: 10.21037/cdt-24-529. Epub 2025 Jun 26.
2
Global research trends and basis of venous/lymphatic malformations during 2003-2023: a bibliometric study over two decades.2003 - 2023年期间静脉/淋巴管畸形的全球研究趋势与基础:一项二十年的文献计量学研究
Front Med (Lausanne). 2025 Apr 17;12:1555168. doi: 10.3389/fmed.2025.1555168. eCollection 2025.
3
Assessment of postoperative pain in children following sclerotherapy of vascular malformations: a retrospective single centre cohort study.
血管畸形硬化治疗后儿童术后疼痛的评估:一项回顾性单中心队列研究。
Eur J Anaesthesiol Intensive Care. 2024 May 23;3(3):e0053. doi: 10.1097/EA9.0000000000000053. eCollection 2024 Jun.
4
When, where and which PIK3CA mutations are pathogenic in congenital disorders.PIK3CA基因的哪些突变在先天性疾病中具有致病性,以及这些突变发生的时间和位置。
Nat Cardiovasc Res. 2022 Aug;1(8):700-714. doi: 10.1038/s44161-022-00107-8. Epub 2022 Aug 8.
5
Musculoskeletal glomus tumor: a review of 218 lesions in 176 patients.肌肉骨骼血管球瘤:176例患者218处病损的回顾分析
Skeletal Radiol. 2025 Mar;54(3):457-479. doi: 10.1007/s00256-024-04743-y. Epub 2024 Jul 30.
6
General anesthesia for cesarean section in a pregnant woman with systemic vascular malformation: a case report.一名患有系统性血管畸形的孕妇剖宫产的全身麻醉:病例报告
JA Clin Rep. 2023 Dec 14;9(1):88. doi: 10.1186/s40981-023-00682-0.
7
Pathophysiology of Slow-Flow Vascular Malformations: Current Understanding and Unanswered Questions.缓慢血流性血管畸形的病理生理学:当前认识与未解决的问题
J Vasc Anom (Phila). 2023 Jul 10;4(3):e069. doi: 10.1097/JOVA.0000000000000069. eCollection 2023 Sep.
8
ErbB signaling is a potential therapeutic target for vascular lesions with fibrous component.ErbB 信号转导是伴有纤维成分的血管病变的潜在治疗靶点。
Elife. 2023 May 18;12:e82543. doi: 10.7554/eLife.82543.
9
Multicentered analysis of percutaneous sclerotherapies in venous malformations of the face.面部静脉畸形经皮硬化治疗的多中心分析
Front Med (Lausanne). 2022 Dec 13;9:1066412. doi: 10.3389/fmed.2022.1066412. eCollection 2022.
10
Regression of a venous malformation during angiotensin-converting enzyme inhibitor treatment for hypertension.高血压患者在接受血管紧张素转换酶抑制剂治疗期间静脉畸形消退。
J Vasc Surg Cases Innov Tech. 2022 Sep 17;8(4):657-659. doi: 10.1016/j.jvscit.2022.09.004. eCollection 2022 Dec.